tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co Ltd (JP:4521)
:4521

Kaken Pharmaceutical Co (4521) Revenue

Compare
0 Followers

Kaken Pharmaceutical Co Revenue

Kaken Pharmaceutical Co had a revenue of 18.05B in the quarter ending Mar 31, 2026, with -26.70%. This bring the company's revenue in the last twelve months to 94.03B, Decreased 0.73%. In the fiscal year ending Mar 31, 2026, Kaken Pharmaceutical Co had annual revenue of 94.03B with 30.52% growth.
Revenue (ttm)
94.03B
Revenue Growth
-5.99%
P/S Ratio
1.65
Revenue/Employee
¥82,850,220
Employees
1,135
Market Cap
¥155.06B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
94.03B21.99B+30.52%
Mar 31, 2025
72.04B-940.00M-1.29%
Mar 31, 2024
72.98B-3.05B-4.01%
Mar 31, 2023
76.03B1.05B+1.41%
Mar 31, 2022
74.98B-14.26B-15.97%
Mar 31, 2021
89.23B-4.93B-5.24%
Mar 31, 2020
94.17B-4.26B-4.33%
Mar 31, 2019
98.43B-3.56B-3.49%
Mar 31, 2017
101.99B